Background: Diabetic nephropathy is the leading cause of end-stage renal disease in the USA, yet most patients with type 2 diabetes mellitus are not formally evaluated with a renal biopsy. Our aim was to evaluate the prevalence of nondiabetic renal disease (NDRD) in patients with type 2 diabetes mellitus to determine common clinical indicators suggestive of NDRD. Methods: A retrospective analysis was performed on biopsy reports of patients who had undergone native renal biopsy between January 1, 1995, and December 31, 2005. Results: After exclusion of 57 patients, 233 patients with DM2 were included in our analysis. Mean age at the time of biopsy was 58.1 ± 13.7 years, and 53.0% of the study population were male. There were 124 cases (53.2%) with a pathologic diagnosis of NDRD, 64 (27.5%) with pure diabetic glomerulosclerosis (DGS) and 45 (19.3%) with concurrent NDRD and DGS (CD). Patients with NDRD tended to be younger than those with DGS and had significantly less associated diabetic retinopathy. Focal segmental glomerulosclerosis was the most common lesion found in patients with NDRD and accounted for 21.0% of all NDRD, followed by minimal-change disease (15.3%). IgA nephropathy (15.6%) and membranous glomerulonephritis (13.3%) were the most prevalent lesions found in patients with CD. Conclusions: The high prevalence of NDRD found in our population underscores the need for clinicians to consider renal biopsy in diabetic patients with an atypical clinical course, since additional disease-specific therapies may be helpful for this subset of the population.

Keywords:
Renal biopsy, Diabetic nephropathy, Glomerular disease, Retinopathy, Hematuria, Proteinuria
1.
Skyler JS: Microvascular complications. Retinopathy and nephropathy. Endocrinol Metab Clin North Am 2001;30:833–856.
2.
Rabkin R: Diabetic nephropathy. Clin Cornerstone 2003;5:1–11.
3.
Kikkawa R, Koya D, Haneda M: Progression of diabetic nephropathy. Am J Kidney Dis 2003;41(suppl 1):S19–S21.
4.
Atkins RC, et al: Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis 2005;45:281–287.
5.
Sessa A, et al: IgA nephropathy complicating diabetic glomerulosclerosis. Nephron 1998;80:488–489.
6.
Hironaka K, et al: Nondiabetic renal disease complicating diabetic nephropathy. J Diabet Complications 1991;5:148–149.
7.
Monga G, et al: Pattern of double glomerulopathies: A clinicopathologic study of superimposed glomerulonephritis on diabetic glomerulosclerosis. Mod Pathol 1989;2:407–414.
8.
Lai FM, et al: Diabetic patients with IgA nephropathy and diabetic glomerulosclerosis. Mod Pathol 1993;6:684–690.
9.
Yoshikawa Y, et al: Membranous glomerulonephritis in diabetic patients: A study of 15 cases and review of the literature. Mod Pathol 1990;3:36–42.
10.
Amoah E, et al: Clinical identification of nondiabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction. Am J Nephrol 1988;8:204–211.
11.
Richards NT, et al: Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus. Nephrol Dial Transplant 1992;7:397–399.
12.
Gambara V, et al: Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol 1993;3:1458–1466.
13.
Orfila C, et al: IgA nephropathy complicating diabetic glomerulosclerosis. Nephron 1998;79:279–287.
14.
Kimmelstiel P, Wilson C: Intercapillary lesions in glomeruli of kidney. Am J Pathol 1936;12:83–97.
15.
Levey AS, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461–470.
16.
Cohen RA, Brown RS: Clinical practice. Microscopic hematuria. N Engl J Med 2003;348:2330–2338.
17.
Tone A, et al: Clinical features of non-diabetic renal diseases in patients with type 2 diabetes. Diabetes Res Clin Pract 2005;69:237–242.
18.
Prakash J, et al: Non-diabetic renal disease in patients with type 2 diabetes mellitus. J Assoc Physicians India 2001;49:415–420.
19.
Olsen S, Mogensen CE: How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature. Diabetologia 1996;39:1638–1645.
20.
Kasinath BS, et al: Nondiabetic renal disease in patients with diabetes mellitus. Am J Med 1983;75:613–617.
21.
Wong TY, et al: Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies. Diabetes Care 2002;25:900–905.
22.
Soni SS, et al: Nondiabetic renal disease in type 2 diabetes mellitus. Nephrology (Carlton) 2006;11:533–537.
23.
Manno C, et al: Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 2004;66:1570–1577.
24.
Colvin RB: The renal allograft biopsy. Kidney Int 1996;50:1069–1082.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.